The draft pharma policy’s plan to do away with loan licensing would lead to revenue loss for SMEs, disrupt the supply chain and make installed capacities redundant, says industry
…
The draft pharma policy’s plan to do away with loan licensing would lead to revenue loss for SMEs, disrupt the supply chain and make installed capacities redundant, says industry
…